LUGANO, June 28th, 2021 • Swissmedic approved Cerbios’ new HPAPI plant Cerbios-Pharma is pleased to announce the approval by Swissmedic of its new HPAPI plant, which forms the latest addition to its plan of expansion into the manufacture of highly potent drug substances. This new production line is dedicated to highly active products with containment…
LUGANO, April 7th, 2020 • From April 1st 2020 the 400 MHz NMR is fully operational in Cerbios. The new equipment expands Cerbios’s already outstanding analytical chemistry capabilities, which now comprise the 400 MHz NMR, HR-Q-TOF mass spectrometer, DSC and UPLCs in addition to all of the most common equipment and techniques. The new instrument…
LUGANO, April 19th, 2018 • Cerbios-Pharma SA (from now on “Cerbios”) is pleased to announce the publication of a comprehensive review on its proprietary Probiotic Active Ingredient E. faecium SF68® (SF68®). In an article, published in the Scientific Journal “Beneficial Microbes”, extensive information is provided on the efficacy and safety of SF68® supported by well established scientific and surveillance…
LUGANO, June 1st, 2017 • Cerbios-Pharma SA is pleased to announce that Mr. Denis Angioletti has joined our team as Chief Commercial Officer and Francesca Nembri is our new Qualified Person and QA/DRA Director. Andrea Tam (former CCO) has been promoted to CEO of a Cerbios’ sister company and Clarissa Gobetti (former QP) has also…
Stockholm/Lugano, April 25th, 2017 • It is a pleasure to share the latest diffusion study results on the AKVANO® drug delivery system developed and owned by our partner Lipidor AB (from now on LIPIDOR). Results from the new in vitro permeation experiments, which have been performed on ketoprofen, diclofenac diethylamine and diclofenac sodium formulations in…
LUGANO, January 1st, 2017 • Following a corporate restructuring and the streamlining of operations at Cerbios-Pharma SA (from now on CERBIOS), we are proud to announce the promotion of Claudio Pozzoli to the position of Chief Scientific Officer (CSO). Claudio Pozzoli will lead the newly created R&D Division, which includes both divisions: Chemical and Biological.…
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
